Minneapolis, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Life Epigenetics, the insurtech subsidiary of GWG Holdings, Inc. (Nasdaq:GWGH), announced that its chief executive officer, Jon Sabes, will speak at the Best Practices event on Innovation sponsored by Plug And Play in Sunnyvale, CA on Tuesday, Dec. 5.
Sabes will speak at the daylong program for the corporate partners of Plug and Play, an accelerator and venture fund based in Silicon Valley.
“This is part of our strategy of telling our story to a wider audience of companies in the insurance industry.” Sabes said. “We want to build on the excitement we have been generating and the Plug and Play event is a great place to do it.”
Life Epigenetics holds the exclusive license for lifespan-predictive technology developed at the University of California, Los Angeles (UCLA) for the life insurance industry. Since February the company has been collecting and analyzing data from life insurance policyholders and has been discussing its work with major life insurance and reinsurance companies that have expressed interest in learning more about how the technology can add value to their businesses. In October, it has announced pilot programs with two life insurance companies to test its epigenetic-based M-Panel technology.
About Life Epigenetics
Life Epigenetics is the insurtech subsidiary of GWG Holdings, Inc. (Nasdaq:GWGH) that is dedicated to creating new technology that is transformative to the way life insurance and financial services underwrite and deliver longevity-based products and services. The company’s “DNA methylation-based predictor of mortality technology,” exclusively licensed from the University of California, Los Angeles (UCLA), provides unprecedented new insight into longevity using the cutting edge science of epigenetics.
For more information about Life Epigenetics, Inc., visit www.lifeegx.com
About GWG Holdings, Inc.
GWG Holdings, Inc. (Nasdaq:GWGH) is a financial services company committed to transforming the life insurance industry through disruptive and innovative products and services. The company owns Life Epigenetics and GWG Life. GWG Life is developing a suite of new longevity-based products for consumers and financial advisors under the LifeCare Xchange (LCX). The LifeCare Xchange provides consumers owning life insurance with the opportunity to exchange their life insurance into products that can be used to pay for long-term care and meet other retirement financial needs. Life Epigenetics is developing transformative M-Panel epigenetic technology to disrupt traditional life insurance underwriting practices. Since 2006, GWG Life has provided seniors over $436 million in exchange value for their life insurance and, as of June 30, 2017, owns a portfolio of over $1.5 billion in face value of policy benefits.
For more information about GWG Holdings, Inc. email info@gwglife.com or visit www.gwgh.com.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/9bb8177c-a708-409a-8f41-66af93cbd346
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a1d4017e-e638-413a-aa8a-74c649a6c2c5